A detailed history of Sheaff Brock Investment Advisors, LLC transactions in Biovie Inc. stock. As of the latest transaction made, Sheaff Brock Investment Advisors, LLC holds 51,400 shares of BIVI stock, worth $20,560. This represents 0.0% of its overall portfolio holdings.

Number of Shares
51,400
Previous 13,638 276.89%
Holding current value
$20,560
Previous $17,000 58.82%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

BUY
$0.53 - $1.89 $20,013 - $71,370
37,762 Added 276.89%
51,400 $27,000
Q4 2023

Feb 08, 2024

BUY
$1.22 - $5.24 $16,638 - $71,463
13,638 New
13,638 $17,000

Others Institutions Holding BIVI

About BIOVIE INC.


  • Ticker BIVI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 30,165,300
  • Market Cap $12.1M
  • Description
  • BioVie Inc., a clinical stage biotechnology company, engages in the discovery, development, and commercialization of drugs therapies in the United States. Its products in pipeline include BIV201, which completed Phase IIa clinical trial for the treatment of ascites due to chronic liver cirrhosis; and NE3107, which is in Phase III clinical trial ...
More about BIVI
Track This Portfolio

Track Sheaff Brock Investment Advisors, LLC Portfolio

Follow Sheaff Brock Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sheaff Brock Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sheaff Brock Investment Advisors, LLC with notifications on news.